Docetaxel (TAXOTERE)
Docetaxel is the first FDA-approved chemotherapy for advanced prostate cancer. This medicine is in a class of medications called taxanes. It works by blocking cell division which results in cancer cell death.
Docetaxel is the first FDA-approved chemotherapy for advanced prostate cancer. This medicine is in a class of medications called taxanes. It works by blocking cell division which results in cancer cell death.